Combination therapy for effecting weight loss and treating obesity
CA 2686633 A1 · Owner: Najarian, Thomas · Inventors: Najarian, Thomas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention features a novel therapy for effecting weight loss which involves treating a subject with a , sympathomimetic agent (e.g. phentermine or a phentermine-like drug) in combination with an anticonvulsant sulfamate derivative (e.g. topiramate) such that the subject experiences weight loss. The combination methods of the present invention also are effective against symptoms associated with Syndrome X. The invention also features pharmaceutical compositions and kits for use in the practice of these novel therapies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 14, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.